This inventor holds 1 USPTO granted patent and 7 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Taher Nasser - Innovator in Multiple Sclerosis Treatment
Introduction
Taher Nasser is an inventor based in Tur'an, IL, who has made significant strides in the field of medical treatments. His work focuses on innovative methods for treating multiple sclerosis (MS), a chronic disease that affects the central nervous system. Although he currently holds no granted patents, his contributions to the field are noteworthy.
Latest Patent Applications
Taher Nasser's latest patent application is titled "METHODS FOR TREATING MULTIPLE SCLEROSIS." This invention is directed to a method for treating or preventing multiple sclerosis, alleviating its symptoms, or preventing the continual chronic deterioration caused by the disease. The method involves administering a conjugate of hydroxyproline and docosahexaenoic acid (DHA) according to the formula MW-001. This innovative approach aims to improve the quality of life for those affected by MS.
Conclusion
Taher Nasser's work in developing methods for treating multiple sclerosis showcases his commitment to advancing medical science. His innovative approach has the potential to make a significant impact on the lives of individuals suffering from this challenging condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile